tiprankstipranks
Drugs Made In America Acquisition II Corp. (DMII)
NASDAQ:DMII
US Market

Compare Drugs Made In America Acquisition II Corp. (DMII) vs. Competitors

1 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Drugs Made In America Acquisition II Corp.
$655.09M
-145.41
1.11%
M3-Brigade Acquisition V Corp. Class A
$10.87
$390.64M
0.05
6.26%
Oaktree Acquisition Corp. III Life Sciences Class A
$10.65
$261.81M
27.87
5.45%
Translational Development Acquisition Corp.
$10.60
$232.11M
28.35
4.95%
Drugs Made In America Acquisition Corp.
$10.52
$352.43M
27.03
4.84%
Archimedes Tech SPAC Partners II Corporation
$10.43
$308.62M
37.11
4.61%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
DMII
Drugs Made In America Acquisition II Corp.
9.99
0.11
1.11%
MBAV
M3-Brigade Acquisition V Corp. Class A
10.87
0.64
6.26%
OACC
Oaktree Acquisition Corp. III Life Sciences Class A
10.65
0.51
5.03%
TDAC
Translational Development Acquisition Corp.
10.60
0.51
5.00%
DMAA
Drugs Made In America Acquisition Corp.
10.52
0.48
4.73%
ATII
Archimedes Tech SPAC Partners II Corporation
10.43
0.46
4.61%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts